C

CVRx | Barostim Tech Stack

Implantable medical device company treating heart failure via baroreflex stimulation

Medical Equipment Manufacturing Minneapolis, MN 201–500 employees Founded 2001 Public Company

CVRx manufactures Barostim, an implantable device that activates the body's natural blood-pressure regulation system to treat heart failure and hypertension. The company is sales-led (19 of 39 open roles) with acute pressure on market adoption and on-time launches—pain points that, paired with active projects around new-site rollouts and in-service training, suggest a scaling phase hitting operational friction around field execution and customer enablement.

Tech Stack 11 technologies

Core StackSalesforce Windows Excel Word PowerPoint Microsoft Project LinkedIn Meta X Five9 FMEA

What CVRx | Barostim Is Building

◆Challenges

On-time product launches
Driving market development
Meeting sales targets
Adoption of cvrx technologies
Maintaining legacy firmware architecture
Field issue resolution
Recruiting specialized roles
Strengthening quality system
Improving post-market performance
Budget constraints

▲Active Projects

R&d support for product enhancements
New product development
Pre-clinical studies
In-service education programs
Resource development and deployment to meet patient implant and revenue goals
Development of therapeutic programs
Product demonstrations and training
Launch cvrx programs at new customer sites
Trade show representation
Implant procedure support

Hiring Activity

Accelerating40 roles · 30 in 30d

Department

Sales

19

Engineering

4

Research

4

Healthcare

3

Support

3

Finance

1

HR

1

Legal

1

Seniority

Senior

13

Junior

12

Mid

6

Manager

4

Principal

2

Director

1

VP

1

Company intelligence

Find more companies like CVRx | Barostim by tech stack, pain points and active projects

Get started free

About CVRx | Barostim

CVRx is a public medical-device manufacturer (NASDAQ: CVRX) headquartered in Minneapolis. The core product, Barostim, is an implantable technology that triggers carotid baroreceptors to signal the brain to regulate cardiovascular function, used in the treatment of heart failure and high blood pressure. The company operates across pre-clinical studies, product development, and post-market support. Revenue is tied to implant procedure volume, driving active focus on customer site launches, field training, and adoption programs.

HeadquartersMinneapolis, MN

Company Size201–500 employees

Founded2001

Hiring MarketsUnited States

Frequently Asked Questions

What is CVRx's main product?

Barostim is an implantable device that stimulates carotid baroreceptors to regulate blood flow and treat heart failure and high blood pressure through the body's natural baroreflex mechanism.